Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

October 1, 2014

Efficacy, Safety and Pharmacokinetics of Teriflunomide in Pediatric Patients With Relapsing Forms of Multiple Sclerosis (TERIKIDS)

  • MS Research Study and Reports
    /
  • Pediatric MS
    /
  Purpose Primary Objective: To assess the effect of teriflunomide in comparison to placebo on disease activity measured by time…
MS Research Study and Reports

October 1, 2014

Study Finds Link Between MS and Schizophrenia Risk

  • Misc. Research Reports
    /
Analyzing a large medical database, researchers have found that patients with MS have an increased risk of bipolar disorder. Researchers…
Misc. Research Reports

October 1, 2014

Pilot Study Finds Stem Cell Treatment Safe for MS Patients

  • Multiple Sclerosis
    /
  • Stem Cell Related
    /
Source: MSFYI newsletter – August 2014 Researchers found that stem cell transplantation may be safe and feasible for MS patients.…
Multiple Sclerosis

September 30, 2014

Multiple Sclerosis Patients Successfully Replace Damaged Cells With New Healthy Stem Cells; First Treatment With Placenta

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
  • Stem Cell Related
    /
Multiple sclerosis patients show improvement when damaged cells are replaced with placenta.Photo courtesy of Shutterstock Sept 29, 2014 Multiple sclerosis is…
MS Research Study and Reports

September 29, 2014

Secondary Progressive Multiple Sclerosis (SPMS) in Australia

  • SPMS-PPMS News
    /
The MIS416 trial is a clinical research trial now enrolling patients with Secondary Progressive Multiple Sclerosis (SPMS) in Australia. Full…
SPMS-PPMS News

September 29, 2014

Orphan Drug Designation Granted to Treatment for Rare Multiple Sclerosis Drug Complication known as PML

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
The Food and Drug Administration granted Orphan Drug Designation to Inhibikase Therapeutics’, Inc. lead product, IkT-001Pro (imatinib), to treat progressive multifocal leukoencephalopathy (PML).  According…
Alternative therapies and devices for Multiple Sclerosis (MS)

September 29, 2014

Low Dose Naltrexone May Improve Multiple Sclerosis Patient Quality of Life

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
  • LDN
    /
Low dose naltrexone (LDN) may be on its way to becoming a new therapeutic agent for multiple sclerosis. Evidence for its efficacy…
Alternative therapies and devices for Multiple Sclerosis (MS)

September 29, 2014

Kessler Study Recommends Wellness Program for Multiple Sclerosis

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
In today’s healthcare environment, it is often not enough that patients are provided with the latest treatments. Good health is…
Alternative therapies and devices for Multiple Sclerosis (MS)

September 29, 2014

What do we know about Alemtuzumab (Lemtrada) – a New ingredient and Form of Treatment therapy

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
Dr. Kantor talks with Dr Alasdair Coles, Neurologist at the University of Cambridge, UK about current information on Alemtuzumab (Lemtrada).…
MS Drug Therapies

September 29, 2014

Multiple Sclerosis Cases Continue To Rise in Countries With Traditionally Small MS Populations

  • MS Views and News
    /
  • Multiple Sclerosis
    /
Recent research continues to suggest that MS is on the rise is countries that in the past posted small diagnoses…
MS Views and News

Categories

Latest Blog Posts